But as summer nears, health experts are warning against the consequences of excessive sun exposure. Here’s what t to know about skin cancer.
Author: Adrianna Rodriguez, USA TODAY
‘Be picky’ about sugary drinks. New study links them to early death in certain people.
Sugary drinks like soda and lemonade were linked to a higher risk of developing heart disease and premature death in people with Type 2 diabetes.
COVID led to the biggest drop in births in 50 years. But not in every state.
A study found that while the national fertility rate dropped during the pandemic, not all states were impacted the same way.
In ‘major breakthrough,’ new test can detect Parkinson’s disease before symptoms appear
A study sponsored by the Michael J. Fox Foundation finds a test of spinal fluid may be able to predict who is likely to develop Parkinson’s disease.
What does long COVID do to kids? What we’ve learned after a year of research.
We now know that between 5% to 10% of kids develop a wide range of health problems called post-COVID conditions or long COVID.
A ‘blueprint’ for longevity: New study has an answer for why some people live to be over 100
Scientists found people who live to be 100 or older – called centenarians – may have a unique immune profile that’s highly protective against disease.
The argument for making alcohol more expensive: It could save lives, study suggests.
The Scottish government made alcoholic drinks more expensive – and it saved people’s lives. Could this be implemented in the United States?
‘Urgent threat’: CDC warns against Candida auris, a drug-resistant fungus invading health care facilities
The CDC is calling Candida auris, a deadly fungal infection, an ‘urgent threat’ as screened cases have tripled from 2020 to 2021.
RSV vaccines for babies and adults are on the way. Here’s what the CDC is saying about them.
RSV vaccines for babies, older adults and pregnant people are in the works from several companies. Here’s the latest data and information.
‘Exciting’ drug could become new male birth control. Here’s how it’s different from the rest.
While the road from mice models to humans may take years, the demand for male birth control options will continue to grow, experts say.